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SUMMARY 
The sole demonstrated enzyme of carbamyl phosphate synthesis in Neurospora 
appears to serve only the arginine pathway. The enzyme is completely absent in 
arg-3 mutants, which require arginine. While pyrimidine synthesis requires carbamyi 
phosphate, pyrimidine synthesis is unimpaired in arg-3 mutants. This suggests the 
existence of a pyrimidine-specific mode of carbamyl phosphate synthesis, and gene 
interaction experiments in support of this notion are presented. The regulatory be- 
havior of arginine and pyrimidine enzymes in mutant strains also reinforces the 
hypothesis that dual modes of carbamyl phosphate synthesis prevail in this organism. 
INTRODUCTION 
Arginine and pyrimidine synthesis in most organisms investigated is dependent 
upon a single precursor, carbamyi phosphate1, 2. In the pathway of arginine synthesis, 
carbamyl phosphate and ornithine react to form citrulline, a reaction catalyzed by 
ornithine transcarbamylase (EC 2.I.3.3). In the pathway of pyrimidine synthesis, 
carbamyt phosphate and aspartate react to form nreidosuccinic acid, a reaction 
catalyzed by aspartate transcarbamylase. It has generally been assumed that the 
transcarbamylases compete for a single pooi of carbamyl phosphate, which in turn 
is the product of a single enzyme. While the substrates and the enzyme of carbamyl 
phosphate synthesis may differ in various organisms, the diagrammatic represen- 
tation below embraces the general scheme: 
- - - - - ~  Ornithine 
Ornithine transcarbamy!ase -R 
> Carbamyl  Phospha te  
@ Aspartate transcarbamylase 
- - . - - ->  Aspar ta te  
;. Citrulline --> Arginine 
-> Ureidosuccinic acid ..... -~ Uridylate 
Abbreviat ions  : CAParg and CAPp~,r, carbamyl  phospha te  pools specific for the arginine and 
pyrimidine pa thways ,  respectively. 
Biochim. Biophys. dora, IO 7 (I965) 54-68 
CARBAMYL PHOSPHATE METABOLISM IN NEUROSPORA 55 
This scheme has in fact been shown to prevail in Eschefichia coli,3, ~ although the 
substrates and the end-product regulation of the enzyme of carbamyl phosphate 
synthesis in this organism remain to be defined clearly 4. 
The present paper will test the hypothesis, developed previouslyS, 6, that in 
Neurospora, there are two modes of carbamyl phosphate synthesis and two corre- 
sponding pools of carbamyl phosphate in the intact, normal cell. Each pool is specific 
for one of the two pathways dependent upon this compound, as indicated in the 
following diagram : 
+ Ornithine 
0rnithine trancarbamylase + 
CAParg 
CAPpyr 
@ Aspartate transcarbamylase 
Aspar ta te  
Citrulline - - - - - -+ Arginine 
Ureidosuccinic acid - > Uridylate  
CAParg and CAPD~r are symbols given to the two independently synthesized carbamyl 
phosphate pools. The previous data upon which this hypothesis is based are indirect, 
although extensive. The most important of these may be summarized as follows: 
The pyrimidine mutant  pyr-3~ is suspected of a CAPpvr deficiency 5. I t  will grow 
without uridine, however, if a second gene, arg-z2 s, is introduced into the genomeT, s. 
The latter gene has the effect of lowering ornithine transcarbamylase activity to 
a level of 3 % normalS. This suggests that if CAPpyr synthesis is prevented by the 
pyr-3ct mutation, an ornithine transcarbamylase deficiency diverts CAParg to the 
pyrimidine pathway. In a completely symmetrical fashion, the mutant  arg-2, sus- 
pected of a CAParg deficiency ~,9,1°, will grow without arginine if another mutation, 
pyr-3d, is introduced 1°. The pyr-3d mutation eliminates aspartate transcarbamylase 
activity 11. This suggests that if CAParg synthesis is disrupted by the arg-2 mutation, 
an aspartate transcarbamylase deficiency diverts CAP~yr to the arginine pathway. 
These conclusions were reinforced by the observation that the pyr-3ct, arg-z2 s double 
mutant  regained a uridine requirement in the presence of arginine, as though pyrimi- 
dine synthesis here were dependent upon an arginine-inhibitable or -repressible stepS, s. 
Exact ly the same conclusions have been reached by CHARLES 12,13 through an analysis 
of similar mutants by patterns of carbon dioxide utilization for growth, and by 
]5"AIRLEY AND WAMPLER 14 through observations of c~-aminobutyrate-supported growth 
of a mutant  similar to pyr-3a. The same relationships between arginine and pyri- 
midine synthesis have recently been shown to prevail in yeast 15. 
The results presented below will show that  extracts of strains carrying the 
arg-3 mutation (unlinked to arg-2, mentioned above) are completely deficient in 
carbamyl phosphokinase (EC 2.7.2.2) activity as measured previously 16. Since this 
activity will be shown to be biologically relevant only to the arginine path (that is, 
it is formally equivalent to the enzyme of CAParg  formation) a pyrimidine-specific 
mode of carbamyl phosphate synthesis, which is detectable in vivo, is clearly not 
being measured in vitro. A hypothesis regarding the segregation of the two modes 
of carbamyl phosphate synthesis in the intact normal cell is presented in the dis- 
cussion. A preliminary note on this work has appeared previously iv. 
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I~ATERIALS AND METHODS 
Materials 
Neurosporc~ crassa strains used in this work are described in Table L Ai] were 
from the author's stock collection, and they are available from the Funga] Genetics. 
Stock Center, Dartmouth College, Hanover, N.H. (U.S.A.)~ Some mn]tiple mutants 
were derived from crosses and are mentioned in the text. Stock cultures and conidiM 
inocula were grown in VOCEL's ~s medium; 2oo ~,g arginine. HC1/ml and !oo ~g 
uridine/ml were added where necessary. 
TABLE I 
NIgUROSPORA STRAINS USED IN THIS STUDY 
Strain or locus 
"number and 
isolation number 4° 
Requireme~,t E~zymic deficiency Refeve~zce 
\Vild type (73a) None None 39 
Wild type (74 A) None None 39 
Argo5 (UM-245) Arginine Argininosuccinate synthetase 25, 27 
Arg-2 (33442) Arginine Unknown 
Arg-3 (3o3oo) Arginine Carbamyl phosphokinase This p~per 
Aeg-~2 (UlX¢-3) Arginine Ornithine t ranscarbamylase 32 
Arg-52s (s) None Ornithine t ranscarbamylase (3 ~o normal) 5, I9 
Pyr-z (263) Uridine Dihydroorotate dehydrogenase or 
dihydroorotase Unpublished 
Pyr-3a (373Ol) Uridine Possibly syn~chesis of CAP~yr 5, 6, i t  
Pyr-3d (45 5 o2) Uridine Aspartate  t ranscarbamylase i I 
L~Arginine. HC1 and uridine were obtained from California Corporation for 
Biochemical Research, or from Sigma Chemical Co. L-Ornithine. HC1 and ATP were 
obtained from Sigma Chemical Co. KHI~CO~ and [t4C~]aspartate were obtained from 
Volk Radiochemical Company. [~4C]Ureidosuccinate was made enzymatically from 
[14C]aspartate, purified, and verified as such by cochromatography with pure, non- 
isotopic ureidosuccinic acid. Ornithine transcarbamyiase was prepared by growing 
the arg-3 strain on limiting arginine supplement, and by purification from acetone 
powders of the mycelium by the method of DAVIS 19. 
METHODS 
Muta~ct selection. Arginine-requiring mutants were isolated after ultraviolet 
irradiation of wild type 74 A by the filtration concentration method of WOODWAP, D, 
DEZEEuW AND SRB 2°. Mutants relevant to this study were identified in regard to 
genetic constitution by crosses to known stock cultures (see RESULTS). 
Growth and extractio~ of mycelia. Mycelia were grown from heavy conidial inocnla 
for 18-24 h in 7oo ml shaken cultures of VOGEL'S medium at 28 ° as described by DAvIs 
AXD HAROLD 2~. The inoculum was adjusted to give an approximateiy predetermined 
dry weight (o.4-I.2 g per flask depending upon the experiment) after overnight 
growth. Where transfers of mycelia to fresh media were done, the myeelia were 
Biochim. Biophys. Acta, IO 7 (I965) 54 68 
CARBAMYL PHOSPHATE METABOLISM IN NEUROSPORA 57 
harvested in a Buchner funnel, washed thoroughly with water without being allowed 
to dry, and introduced into new flasks of medium. Because of the short period of 
growth following transfers, sterility was not a serious consideration during transfer. 
All final harvests were done by drawing mycelia to moist pads on a Buchner 
funnel, and drying them by  pouring acetone (reagent grade) over them. The pads 
were dried quickly in this way, and were used for both dry weight determinations and 
enzyme assays. None of the enzymes in this s tudy were sensitive to this treatment.  
For extraction of enzymes, powders were prepared from the pads by  grinding them 
in cold (--IO °) acetone, followed by drying in air. The powders (Ioo rag) were then 
suspended in 4 ml 0.02 M potassium phosphate buffer (pH 7.o), centrifuged, and the 
supernatant  saved. The residue was extracted again with .I ml of buffer and the 
supernatant  combined with the first. The extracts were dialyzed overnight against 
the same buffer; they could then be frozen indefinitely prior to assay. Protein was 
measured by the biuret method 22. 
A@artate transcarbamylase assay. Reaction mixtures 11 (3.25 ml) contained 
500/*moles g lyc ine-NaOH buffer (pH 9.1); 4o/*moles L-aspartate; 20/,moles freshly 
dissolved dilithium salt of carbamyl phosphate; and a rate-limiting amount of extract. 
After 15 rain incubation at 25 °, 0.5 ml 2 M HC10 4 was added. The tubes were centri- 
fuged and 1.o ml of the supernatant was used for ureidosuccinic acid determination 
by  the method of KO•ITZ AND COHEN 23 as modified by DAVIS 19. Specific activities are 
expressed as /,moles ureidosuccinic acid/mg protein/h. 
Ornithine transcarbamylase assay. Reaction mixtures 19 (3.25 ml) contained 
50o/*moles Tr i s -ace ta te  buffer (pH 9.1); 2o/*moles L-ornithine. HC1; io/*moles 
freshly dissolved dilithium carbamyl phosphate; and a rate-limiting quanti ty of 
extract. After 5 min incubation at 25 °, o. 5 ml 2 M HC10~ was added. The tubes were 
centrifuged and the supernatants were used for citrulline determinations by the 
method used for ureidosuccinic acid. Specific activities are expressed as ~moles 
citrulline/mg protein/h. 
Carbamyl phosphoki~ase assay. Reaction mixtures 16 (o.5 ml) contained 5 °/*moles 
Tris-HCt buffer (pH 8.4); 8/ ,moles MgC12; 30/,moles NH4C1; io / ,moles  KHCO3; 
3/ ,moles ATP; 2.5/*moles L-ornithine. HC1; excess ornithine transcarbamylase; and 
a rate-limiting quanti ty of extract. After 30 min at 37 °, o.1 ml 2 M HCIO~ was added. 
After centrifugation, 0.4 ml of the supernatant was used to determine citrulline in 
one-half volume color reactions by the method used in the transcarbamylase assays. 
A large number of assays were done simultaneously by  the above method and by 
the isotope method described in the previous paper 16, and the two determinations were 
found to give almost exactly the same ratio of/*moles citrulline to counts/min within 
any set of assays. Variations from day to day were ascribable to variations in the 
specific activity of the KH14CO3 substrate used in tile isotope method. For this reason, 
the colorimetric method is used here: specific activities are /,moles citrulline/mg 
protein/h. 
Ureidosuccinic acid determinations. Ureidosuccinic acid, accumulated by  certain 
strains in the course of growth, was extracted from moist pads of mycelium grown 
in shaken cultures, the dry weights of which were determined with an acetone-dried 
replicate sample. The moist pads (the equivalent of about IOO mg dry wt.) were 
extracted successively with 2 ml 0.5 M trichloroacetic acid and two 2 ml volumes of 
water. The extracts were passed through a column of Dowex-5oW (H + form, 200-400 
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mesh, I , i  )( 3 era), and  the eiuate  was made  up to xo m]. The eluate  was tes ted  for 
ureidosuccinic acid  b y  the  color imetr ic  :method ci ted above.  
The i den t i t y  of ureidosuccinic acid was es tabl ished b y  cochromatography  on 
Dowex--I columns of the  ex t r ac t ed  ma te r i a l  wi th  -l~C?ureidosuccinic acid. An ex t rac t  
to which [l~C!ureidosuccinic acid had  been added  was b rought  to p H  7.5 and appl ied  
to the  surface of a Dowex-x column (formate form, 2o0-400 mesh, x.! X S era) 
prev ious ly  equi l ib ra ted  wi th  0.o65 M sodium formate  b rought  to p H  3.5 with formic 
acid. E lu t ion  followed wi th  the  same buffer;  Io -ml  fract ions were collected. 
R a d i o a c t i v i t y  was de t e rmined  wi th  a Nuclear-Chicago D-47 Gas-Flow counter ,  
and  ureidosuccinic acid was de te rmined  b y  the  me thod  of G~RHaRT AND PARDEE2% 
D a t a  re la ted  to i d e n t i t y  of ureidosuccinic acid  are given in the  R~SUZTS. 
R E S U L T S  
Genetic control of c~rbamyl pho@hokin~se 
CarbamyI  phosphokinase  m a y  be de tec ted  in crude, d ia lyzed  ex t rac t s  of all 
s t ra ins  tes ted  except  those ca r ry ing  the  ~rg-3 muta t ion .  Assays  done b y  the co]oft- 
met r ic  me thod  or b y  the  rad ioac t ive  m e t h o d  give p ropor t iona l  results.  Colorimetr ic  
d a t a  for several  s trains,  including arg-3, are r epor ted  in a la te r  section. The  absence 
of de tec tab le  a c t i v i t y  in re'g-3 is p r o b a b l y  not  the  resul t  of a free inhibi tor ,  the  tack 
of a cofactor,  or a compet ing  react ion,  since when ex t rac t s  of roT< S are mixed  with  
those of arg-z2 (having c a r b a m y l  phosphokinase ,  b u t  Iaeking orni thine  t ranscar -  
bamylase)  in rad ioac t ive  assays, the  ac t i v i t y  of the  l a t t e r  is unaffected (Table I I ) .  
TABLE II 
t;FFECT oF arg-3 E X T R A C T  ON T H E  CARBA.~IYL P H O S P H O K I N A S E  R~;ACTION 
Reaction mixtures (o. 5 ml) were standard for the isotope assay. They contained crude dialyzed 
extracts of arg-z2 and arg-3. Ornithine transearbamylase was used only as noted. 
Extracts and enzymes added (mZ) Cownts/min 
per o,4 mZ 
Arg-z2 Arg-3 Ornithine trans- per 30 rain 
carbamylase 
o.I 0.05 126o 
o.1 0.05 4 
o.I o.x 0.05 I337 
0.I II 
o . I  7 
o.I o.I I 2 5 2  
Table  I !  also gives d a t a  showing t h a t  when orni th ine  t r ansca rbamylase  is omi t t ed  
from reac t ion  mix tu res  ne i ther  ~rg-r2 nor arg-3 alone can t rans form rad ioac t ive  
b i ca rbona te  to citrull ine,  b u t  when ex t rac t s  are mixed,  the  ca rbamyl  phosp1-~okinase 
ac t iv i ty  seen is character is t ic  of arg-z2. This ind ica tes  t ha t  the  orni th ine  t r ansca rba -  
mylase  deficiency of arg-i2 is absolute ,  and  t h a t  the  grg- 3 ex t rac t  m a y  replace it. 
The absence of c a r b a m y l  phosphokinase  behaves  as a single gene charac te r  in 
crosses, and  is abso lu te ly  corre la ted  wi th  the  arg-3 nut r i t iona l  phenotype .  The isolate  
of arg- 3 used was verified as such b y  i ts  close l inkage 2~ to the  arg-z locus on chromo- 
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some I (2.6 map units, a value based upon recovery of wild types and double mutants 
in an arg-3 × arg-i cross). 
The work on the genetic control of carbamyl phosphokinase was based wholly 
on experiments with a single allele of ~rg-3 (3o3oo). Confirmation of the arg-3 locus 
as a controlling genetic factor was obtained by selection of new mutants. Arginine- 
requiring mutants were obtained after ultraviolet treatment; the nutritional class 
which grew on citrulline but not on ornithine was investigated enzymatically and 
genetically. Four mutants, comprising one heterokaryon complementation group, 
were found to be completely deficient in carbamyl phosphokinase. Two remaining 
mutants of the same nutritional category which complemented with the first group 
but not with one another had normal carbamyl phosphokinase activity. Crosses of 
all mutants to both arg-3 and arg-2 "strains were performed. Allelism was judged by 
the absence of prototrophic isolates in crosses of mutants, and non-allelism without 
linkage was inferred if one-quarter of the progeny were prototrophic (the double- 
mutants were not easily distinguishable from the parental classes). The results show 
that the enzyme-deficient class is allelic to arg-3; the other class is probably allelic 
to afg-2 as judged by sterility in crosses, though genetic proof is lacking (Table III) .  
TABLE III 
ANALYSIS OF NEWLY ISOLATED MUTANTS 
New mutant Carbamyl 
(isolation phosphokinase : 
number) specific activity 
Proto#,opic isolates % fo~*nd 
when maled to: 
Afg-3 (3o3oo) Arg-2 (33442) 
UM-6o2 o <o.ot 28 
UM-6o 3 o <o.oi 25 
UM-6o 4 o <o.oi 39 
UM-6o 5 o. 19 13 * Sterile 
UM-6o 7 o %o.oz 22 
UM-6o9 o.I8 32 Sterile 
* UM-6o 5 was associated with a genetically complex morphological phenotype which in- 
fluenced the segregation of the arginine genes. 
These results are taken as proof that arg-3 controls the formation of carbamyl phos- 
phokinase, probably as a structural gene. Rigorous proof of ~rg-3 as a structural locus 
would require the demonstration of arg-3 alleles which impose structural or kinetic 
alterations of the enzyme. No partially-deficient strains of this locus have yet been 
studied to test this notion, however. 
In previous experiments, strains carrying arg-2, a mutation unlinked to arg-3 
but virtually indistinguishable from it in any other way, were found to have normal 
carbamyl phosphokinase activity (see also Table III). Since arg-2 strains also contain 
substantial ornithine transcarbamylase activity, the reason they cannot perform 
the ornithine to citrulline conversion in vivo remains quite obscure. This will be 
considered further below. 
Metabolic 25ositio# of carbamyl phosphokinase: nutritional evidence 
The carbamyl phosphokinase activity studied here is apparently specific for 
the arginine pathway, since the arg-3 mutant  does not have a pyrimidine requirement 
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for growth. Furthermore, when uridine is used as a supplement in addition to arginine,, 
the utilization of the latter is not spared (Fig. i). 
The hypothesis that two modes of carbamyl phosphate sy~:~thesis operate was 
based in part upon the effect of the ~yr-3d mutation (deficient in aspartate trar:,s.~. 
carbarnylase) upon the srg-2 phenotype. The double mutant  pyr-sd, arg-z behaves as 
though a pyrimidine precursor (CAPsular) were being diverted to citrulline synthesis, 
2O 
k 
), 10 o /  
,o, 
o lOO 200 
Mg arginine-HCI per rql 
Fig .  ~. E f f e c t  of u r i d i n e  on  t h e  r e s p o n s e  of arg- 3 to a r g i n i n e .  HC1. P o i n t s  r e p r e s e n t  t h e  d r y  w e i g h t s  
,of arg-3 m y c e l i a  in  m e d i a  c o n t a i n i n g  v a r i o u s  c o n c e n t r a t i o n s  of a r g i n i n e .  HCI.  T e n  m l  of m e d i a m  
w a s  i n o c u l a t e d  w i t h  con id i a ,  a n d  m y c e l i a  w e r e  h a r v e s t e d  a f t e r  4 d a y s  s t a t i o n a r y  g r o w t h  a t  25 °, 
O - - O ,  no  u r i d i n e  a d d e d ;  Q-- - - @ ,  Ioo  # u r i d i n e  a d d e d / m l  m e d i u m .  
' T A B L E  IV 
I N T t ~ R A C T I O N  O F  ~ ' g ' - 3  A N D  A L L E L E S  o F  T t t ~  i~jFT~-3 L O C U S  
Arg-3 a n d  t h e  d o u b l e  m u t a n t s  art-3, pyr-3a a n d  art-3, pyr-3d w e r e  g r o w n  in  Io  m l  s t a t i o n a r y  
c u l t u r e s  for  s i x  days .  T h e  m e d i u m  c o n t a i n e d  t h e  c o n c e n t r a t i o n s  of a r g i n i n e .  HC1 a n d  u r i d i n e  
i n d i c a t e d .  
Arginine. HCl Uridine 
(~g/~l) (~/~)  
~Ory weight (n~g/zo ml) 
A rg-3 Arg-3, Pyr-3a Art-3, Pyr-3d 
0 0 0 0 0 
o i o  --- o 6.5 
5 Io  - -  I . i  9.1 
O IOO O O 10.8 
5 i o o  1.6 z . i  i3 .  5 
200 I o o  20.4 23.8 31.7 
thereby reducing the arginine requirement imposed by arg-2 (see ref. 5). Precisely the 
same relationship between pyr-3d and art-3 should obtain; the prediction is all the 
more critical, since arg-3 (in contrast to art-z) has a demonstrable carbamyl phospho- 
kinase deficiency. That  pyr-3d does in fact reverse the nutritional erect  of this 
deficiency is shown in Table IV, where c~rg-3, p>'r-3d is compared to the single mutant  
arg-3 in regard to arginine requirement. A parallel growth experiment was done with 
the double mutant  art-3, ~)yr-3a. This strain would not be expected to have a reduced 
arginine requirement since, according to the general hypothesis, both modes of 
.carbamyl phosphate synthesis are missing (see INTRODUCTION) ,  As shown by the 
da ta  in Table IV, this strain does not, in fact, exhibit a reduced arginine requirement. 
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The exact parallel between these observations and those made by Reissig with 
art-2 reinforces the notion that art-2, like art-3, suffers a perturbation of carbamyl 
phosphate synthesis, at least in vivo. 
Metabolic position of carbamyl pho@hokinase: synthesis of citr,~lline and ureidosuccinic 
acid in vivo 
The pyr-z mutant  is blocked in the synthesis of orotie acid from ureidosuccinie 
acid, and as a result, it accumulates large amounts of ureidosuccinic acid 2~. The arg-z 
mutant lacks argininosuccinate synthetase (EC 6.3-4.5), and thus accumulates citrul- 
line 27. These mutations provide an opportunity to demonstrate the metabolic position 
of carbamyl phosphokinase, since when the double mutants arE-3, arg-2 and arE-3, 
pyr-z are studied, the effects of the carbamyl phosphokinase deficiency upon citrulline 
and ureidosuccinic acid accumulation may be observed. If the carbamyl phospho- 
kinase missing in art-3 strains served both pathways, neither double mutant  would 
accumulate a carbamyl compound. If, on the other hand, the enzyme served only 
the arginine pathway, citrulline would not accumulate in art- 3, arg-I and ureido- 
succinic acid would accumulate in art-3, pyr-;. 
The double mutants were isolated from the appropriate crosses; the genetic 
constitution of arg-3, arg-z was confirmed by outcrossing to wild type, with the 
unambiguous detection of both mutations among the progeny. Unlike extracts of 
the arg-z parent, those of the art-3, arg-z double mutant  contained no accumulated 
citrulline. (In fact, the latter were initially identified in this way.) This demonstrates 
that carbamyl phosphokinase is indispensable for citrulline synthesis. This evidence 
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Fig. 2. Accumulat ion of ureidosuccinic acid by  the  double mutan t ,  art-3, pyr-L  A shaken culture 
of mycel ium grown in 2oo #g  arginine + IOO #g uridine/ml was harvested and t ransferred to 
new medium containing 2oo #g  arginine.HC1 at  o h. The ureidosuccinic acid accumulated is 
measured  subsequent ly  in units  of #moles /g  dry  wt. Weight  increased f rom o.6 g/7oo ml to 
abou t  o.95 g/7oo ml during the exper iment  as endogenous pyrimidines were depleted. 
Fig. 3. Cochromatography  of 8 ffmoles of ureidosuccinic acid accumulated by  art-3, pyr-z  (last 
point  in Fig. 2) with 0.2 ffmole [14C]ureidosuceinic acid (see MXT~IOl)S). - - ,  radioact ivi ty (left 
ordinate);  . . . . .  , ffmoles ureidosuccinic acid (right ordinate). Only a small additional a m o u n t  
(equivalent to 0. 4 ffmole ureidosuccinic acid) of colorigenic material  was found in the ext rac t  
used; this appeared at  the  solvent f ront  (fraction I, not  shown). 
62 R, H. DAV]:; 
The c~rg-3, ]hyr-z double mutant ,  however, is able to accumulate ureidosuccin c 
acid to the same extent as the pF,'r-z single mutant ,  if the two strains are cornpar<d 
on limiting concentrations of uridine: pyr-z accumulated 85 ~moies nreidosuccinic 
acid/g dry wt; arg-3, py>z  accumulated 97 ~moles/g in one experiment; wild type 
contained at most 6 ,amoles/g. The course of ureidosuccinie acid accumu]ation by 
arg-3, pyr-± is shown in Fig. 2, and resembles ureidosuccinic acid accumulation by 
pyr-z reported by  DONACHiE s6. A number of experiments showed that  the extent 
of ureidosuccinic acid accumulation in the double mutant  was inversely related to 
the nridine concentration. This suggests that  the ureidosuccinic acid accumulated 
by  this strain is not merely a metabolic product of the uridine added. Furthermore, 
sufficient arginine was required such that  the uridine supplement was exhausted; only 
after growth ceased as a result of uridine depIetion did ureidosuccinic acid accumu- 
late. The ureidosuccinic acid accumulated by arg-3, pyr-z (a sample of 8 ~mo]es) was 
identified by column chromatography (Fig. 3) with 1~C ureidosuccinic acid Not 
only did the positions of the peaks of radioactivity and color coincide, but the specific 
radioactivity of the ureidosuccinic acid was essentially constant throughout the peak. 
These results demonstrate in a direct fashion the existence of a system capable 
of ureidosuccinic acid synthesis in the absence of demonstrable carbamyl phospho-- 
kinase activity in extracts. They thereby reinforce the designation of this enzyme 
as "arginine-specific". The pyrimidine-specific system of carbamyi phosphate syn- 
thesis postulated above will be taken up in the discussion. At this point, it is sufficient 
to note that  no net synthesis of ureidosuccinic acid has been achieved i~z vi#/o unless 
carbamyl phosphokinase is presentl% 
Metabolic positio~ of earbamyl phosphokinase : regulatio~¢ of e~,~,me c~etivities 
Many enzymic mutants  of Neurospora (like those of bacteria) which are starved 
for their growth-factor requirement respond with an elevation of the specific activity 
of some or all of the remaining enzymes in the deficient pathway. This response may 
be governed through a relief of enzyme repression imposed by the end product of 
the pathway, or through induction by elevated concentrations of non-metabo]izable 
intermediates 2s. In either case, the response (in bacteria, at least) is usual!y speeifi< 
in the sense that  high levels of enzymes are seen only in the synthetic pathway of 
the compound for which the organism is starved. That  this is true of Neurospora is 
shown in a limited fashion in the experiments reported below, where the pathway 
specificity of carbamyl phosphokinase is tested. 
The experiments reported in Table V involved transfers of mycelia to supple- 
mented and unsupplemented media; and a measurement of the activities of ornithine 
transcarbamyiase, aspartate transcarbamylase, and earbamy! phosphokinase. Tab!eVI 
reports enzyme activities of strains grown without transfer in medium with limiting 
arginine or uridine. The experiments were designed to show whether the carbamyi 
phosphokinase observed in normal extracts and lacking in a~'g-3 extracts served both 
the arginine and pyrimidine pathways, or whether it was relevant only to arginine 
synthesis. While the lack of a pyrimidine requirement in aYg-3 would in itself appear 
to rule out the former possibility, it might be argued that  the arginine used to sup- 
plement cfrg-3 is in some way utilized to satisfy a pyrimidine requirement. The most 
significant data related to this question are that  when the arg-3 mutant  (lacking 
carbamyl phosphokinase) is deprived of arginine, only ornithine transcarbamylase 
CARBAMYL P H O S P H A T E  METABOLISM IN N E U R O S P O R A  6 3 
becomes elevated in its activity, while aspartate transcarbamylase remains at normal 
levels. The remainder of the data on the aspartate and ornithine transcarbamylases 
supports the specificity of their responses to starvation for uridine and arginine, 
respectively. The lack of response of aspartate transcarbamylase to arginine depri- 
vation in arg-3 suggests strongly that pyrimidine synthesis is not impeded by the 
lack of carbamyl phosphokinase when this strain is starved for arginine. 
The specificity of carbamyl phosphokinase for the arginine pathway is also 
indicated by its response to the arginine concentration of the medium, and an in- 
difference to uridine in the medium. Evidence of this sort is not as meaningful as 
the transcarbamylase data, since the activity of an enzyme shared by two pathways 
need not, a priori, be influenced by both corresponding end-products. 
Two problems arose in experiments where arginine concentration was studied 
in its effect upon arginine enzymes. The first was that arginine in the medium induces 
arginase activity 29.. Since this enzyme leads to a rapid destruction of arginine, the 
intramycelial concentrations of this compound are difficult to maintain at a known 
T A B L E  V 
SPECIFIC ACTIVITIES OF ASPARTATE TRANSCARBAMYLASE, ORNITHINE TRANSCARBAMYLAStg, 
AND CARBAMYL PttOSPHOKINASE IN VARIOUS STRAINS 
M y c e l i a  w e r e  g r o w n  ill a n d  t r a n s f e r r e d  to  v a r i o u s  m e d i a :  M I N  = u n s u p p l e m e n t e d ;  2 o o A  = 2 o o # g  
a r g i n i n e .  HC1/mI ;  I o o U  ~ i o o / z g  u r i d i n e / m l .  
Strain Original Transfer h after A spartate Ornithine Carbamyl 
medium medium transfer transearbamylase transcarbamylase phosphokinase 
W i l d  M I N  o 4. I 14 o. 15 
M I N  5 2.8 18 o . i 8  
I o o U  5 2.8 21 o.13 
2 o o A  5 3 .2 21 o.13 
Arg-z 2 o o A  o 4.2 30 o . i 8  
M I N  5 1.9 53 0.26 
2 o o A  5 1.6 3 ° 0 .09 
Arg-3 2 o o A  o 5.0 28 o 
M I N  5 4.5 52 o 
2 o o A  5 3 .8 25 o 
A~'g-i2 2 o o A  o 4.0 o o.17 
M I N  4 4,5 o o.18 
2 o o A  4 3 .2 o o.o 5 
Arg-i2s M I N  o 2,8 0.64 0.42 
M I N  5 2.2 0.76 0.53 
2 o o A  5 2.4 0.34 0.24 
Arg-z2s 2 o o A  o 3.9 0.37 0.25 
M I N  5 1.9 0.94 0.42 
2ooA 5 2.4 0.29 o.o8 
~Pyr-z I o o U  o 2.5 13 o.13 
M I N  4 1°-4 16 o .16  
I o o U  4 4 .2 I8  o.2o 
Pyr-3a I o o U  o 3.0 17 o.18 
M I N  5 I2 .o  I 3  o . I 9  
I o o U  5 3.7 17 o .16  
Pyr-sd I o o U  o o 24 0.25 
M I N  4 o 20 0.24 
I o o U  4 o 26 0.25 
* P e r s o n a l  c o m m u n i c a t i o n ,  of Vq. M. THWAITES. 
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level where arginine is added. Any strain introduced as a eonidia] inoeuium into medial 
containing arginine will have disposed of a large part of i t  even by the earliest time 
(z 7 h) at which enzyme determinations are m.ade~ This accounts for the normal ':£ 
high ornithine transcarbamylase and earbamyl phosphokinase levels found in most 
strains, in contrast to the low levels expected if a repression mechanism prevai]s~ 
However, short term transfer experiments to arginine can be used to demonstrate 
"repression" of carbamyl phosphokinase. 
T A B L E  V r 
]~F FECT OF L I M I T I N G  N U T R I T I O N A L  S U P P L E M E N T S  ON ASPAIRTAT~E T R A N S C A R B A M Y L A S ~  
O R N I T H I N G  T R A N S C A R B A M Y L A S E ,  A N D  C A R B A M Y L  P H O S P H O K I N A S E  
S t r a i n s  w e r e  a l l o w e d  t o  g r o w  f r o m  t h e  t i m e  of i n o c u l a t i o n  t o  t e r m i n a l  d r y  w e i g h t  in  t h e  l i m i t i n g  
c o n c e n t r a t i o n s  of s u p p l e m e n - [  i n d i c a t e d .  E n z y m e  a c t i v i t i e s  a t  t h e  f i r s t  ( p r i o r  to  t e r m i n a l  w e i g h t )  
a n d  a t  t h e  f i n a l  h a r v e s t  a r e  g i v e n .  
Strai~ Sz~ppleme,~t Hafve,~t Asp~r~a,~e O~t,~ilhi,t,ze C~,,ba~,z3,,I 
co~cenlrat'io~:z tra~scaf[)~yZese Manscafba~.),fese lg}~os)/~o/{iezase 
A~,g-z 5 ° a r g i n i n e .  H C I  F i r s t  2. 4 60  o.3~, 
L a s t  2. 4 76 o .44  
Arg-3 5 o a r g i n i n e .  H C i  F i r s t  4 .0  43 o 
L a s t  3.3 85 o 
Arg-i2 50 a r g i n i n e .  HC1 F i r s t  ~.7 o o 2 6  
L a s t  2. 3 o o .56  
Pyf-3 d 25 u r i d i n e  F i r s t  o 25 o ,25  
L a s t  o :r 7 o. 15 
A second problem was that transfers of absolute arginine mutants to fresh 
minimal medium did not result in large alterations of ornithine transcarbamylase 
and carbamyl phosphokinase activity, although the effects of this treatment upon 
the former are clear from Table V. This unresponsiveness to arginine starvation in 
absolute mutants may reflect a sudden impairment of protein synthesis imposed by 
deprivation of arginine. To circumvent this problem, mutants were grown on limiting 
arginine and were allowed to exhaust the supplement. In the process, activities of 
the arginine enzymes increased markedly. The problems associated with transfer 
experiments were also avoided by use of the partially mutant  a r g - z z  s strain, since 
growth of this strain occurs in minimal medium. In this strain, both repression and 
increases of enzyme activity can be seen in transfer experiments. 
Tables V and VI show the influence of arginine and uridine supplementation on 
carbamyl phosphokinase activity. First, -the transfer experiments (Table V show 
repression of carbamyl phosphokinase in mycelia of arginine-requiring strains trans- 
ferred to arginine-containing medium In contrast, carbamv1 phosphokinase is not 
influenced in pyrimidine mutants ~ransferred to uridine. Second. the experiments 
involving limiting supplements (Table VD. show that carbamyl phosphokinase activ- 
ity becomes elevated in conditions of arginine starvation and not in conditions 
of uridine starvation. ]Elevation of this activity is also pronounced in transfers ot 
a r g - z 2  s to minimal medium (Table V). In numerous additional experiments not re- 
ported in the tables, no interaction of uridine and arginme in their effects uuon the 
three enzyme activities could be detected. 
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The clear response of carbamyl phosphokinase to arginine and its lack of 
response to uridine are consistent with the previous conclusion that arginine synthesis 
depends upon this enzyme, but pyrimidine synthesis does not. 
A last point is that  enzymes of the wild type strain are relatively unresponsive to 
supplements in the medium. This suggests that internal intermediate concentrations 
are normally high enough to entail low enzyme activities, and additions to the medium 
have correspondingly little effect. 
DISCUSSION 
The evidence presented indicates in several ways that an arginine-specific 
system of carbamyl phosphate synthesis exists which is distinct from a pyrimidine- 
specific system. The data show that carbamyl phosphate formation in vitro, seen in 
wild type extracts under the conditions of assay used, is eliminated by mutant  alleles 
of the ~rg-3 locus. While the purification of the carbamyl phosphate-forming system 
has not been extensive, there is no reason at this point to feel that the enzyme activity 
seen in vitro is resolvable into two or more sequential steps. In fact, no other mutations 
affecting this activity have been detected. I t  may be concluded, therefore, that arg-3 
is the primary determinant of the activity i~¢ vitro. In the intact cell, however, the 
mode of carbamyl phosphate synthesis which involves this activity may also be 
dependent upon the product of the arg-2 locus, since arg-2 mutants have the same 
phenotype as erg-3 mutants when judged on the basis of nutrition, response to CO 2 
supplementation, and gene interactions. Until the action of the afg-2 locus has been 
demonstrated, the biological steps of carbamyl phosphate synthesis for the arginine 
pathway will be incompletely known. As noted in the previous paper 16, the question 
of the true substrate of carbamyl phosphokinase has not been satisfactorily resolved 
in favor of carbamate. Possibly the formation of an unknown biological substrate 
depends upon the arg-2 locus. 
The evidence regarding the specificity of the carbamyl phosphokinase described, 
to be complete, must ultimately include the demonstration of a pyrimidine-specific 
system in vitro which is clearly separable from it. The data show that ureidosuccinate 
synthesis takes place in strains whose extracts lack the arginine-specific activity, or, 
in fact, any demonstrable capacity for carbamyl phosphate synthesis. While it is 
not certain that carbamyl phosphate is a biological intermediate in ureidosuccinic acid 
synthesis, the fact that  aspartate transcarbamylase is found in Neurospora, that its 
absence leads to a pyrimidine requirement 11, and that its Km for carbamyl phosphate 
is less than 2- Io -4 M (at pH 8.4)2G, * encourages this view. This view is further re- 
inforced by the gene interaction studies which show that arg-3, pyr-3d behaves as 
though CAPpyr is diverted to ornithine transcarbamylase. The attempts to demon- 
strate the synthesis of CAPpyr in vitro (the appearance of ureidosuccinic acid from 
[14Claspartate being taken as a criterion) have been made with a strain carrying 
simultaneously the erg-3, the pyr-z and the arg-zz mutations. While this strain, like 
arg-3, pyr-z, accumulates large amounts of ureidosuccinic acid, even the crudest, 
undialyzed, cell-free preparations fail to engage in net synthesis of this compound 
under conditions used so far. Any transformation of [l~C)aspartate to C14C]ureido - 
* Ic~. H. DAVIS, unpublished results. 
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succinic acid detected so far results from carbamy! exchange from accnmulatc-d 
ureidosuccinic acid. This work shows that  conditions for CAPpyr synthesis (e.g., sub- 
strates, extract preparation, pH), as yet unknown, are quite different than those 
for CAParg synthesis. 
If  the theory of dual modes of carbamyl phosphate synthesis is accepted on the 
basis of the evidence presented, the segregation of the two pools of carbamyl phos- 
phate in the normal cell requires explanation. That  the sources of carbamyl phosphate 
are indeed segregated or channelled may  be inferred from the fact that  single nutri- 
tional requirements arise as a result of mutat ion of each enzyme of carbamyi phos- 
phate synthesis. I t  appears, from the gene interaction studies, that  where only one 
pool of carbamyl phosphate remains (as in a~-3 or pyr-3~), there is a competitive 
relation between the two transearbamylases, since the relationship may be altered 
by  mutations affecting the transcarbamylases ~. For channelling to occur however, 
it is also iogically necessary to have a spatial segregation of at least one pool of 
carbamyi phosphate from the transcarbamylase of the other pathway. 
Previous extensive work on the mutations of the ]byr- 3 lOCUS has led to the 
inference that  the synthesis of CAPp~r and its utilization via aspartate transcarba- 
mylase are activities of a single protein molecule%SO, 3~. This accounts, among other 
things, for the allelism of ibyr-3a and py~'-Jd. Such a hypothesis provides a possible 
mechanism for the channelling of CAPpyr in the normal ceil, since this compound 
could be utilized for ureidosuccinic acid synthesis before entering a diffuse pool 
accessible to ornithine transcarbamylase 6. This would not be true of mutants  like 
15y~'-jd (lacking aspartate transcarbamylase while retaining the ability to synthesize 
CAPpyr), which act to reduce the arginine requirement of arg-2 and a~'g-3 (see ref. Io). 
The bifunctional protein catalyzing ureidosuccinic acid formation is inferred from 
an entirely different type of data obtained from yeast ~. 
The channelling of CAParg to the synthesis of citru!line cannot be understood 
in a similar fashion, since ornithine transcarbamyiase and carbamvI phosphokinase 
are already known to be separable activities, both by the locations of the corresponding 
genes az, and by fractionation procedures. ChanneIling would take place, however, 
if the CAParg pool is an unlocalized one, and if ornithine transcarbamylase has a 
sufficient kinetic advantage over aspartate transcarbamylase in CAParg utilization. 
This advantage would be lost, however, in mutants  carrying the arg-ry mutation 
(low ornithine transcarbamylase), which is known to overcome the effects of ~y~'~*Jao 
This hypothesis to account for channeling is a tentative one, since in limited experi- 
ments with wild tvpe and pyr-3a, conditions i~ vitro which allow more ~han 7o o,, j / 0  
utilization of the product of carbamyI phosphokinase by ornithine transcarbamylasc 
in competition with aspartate transcarbamylase have not yet been found. This is 
accounted for by the greater affinity of the latter enzyme for carbamyl phosphate in 
comparison to the former, despite the 3- to 7-%1d excess in specific activity of ornithine 
transcarbamylase over aspartate transcarbamylase, I t  is possible that  the conditions 
which favor CAPpyr formation will also favor the channelling of CAParg. A similar 
probIem of channelling arises in the best-known case of biosynthetic enzyme duality. 
tha t  of aspartokinase 33. 
Carbamyl phosphate metabolism in Neurospora is complex, and elaborate 
genetic materials are required to display it fully. In view of this, many organisms 
which are less well-known in this regard may prove to be equally complex when 
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better known. A case in point is that of the pigeon and certain extrahepatic tissues 
of the ratl,~m in which pyrimidine synthesis presumably prevails, yet where no 
enzyme catalyzing carbamyl phosphate formation has been demonstrated. It  is 
possible that  a pyrimidine-specific enzyme of carbamyl phosphate synthesis exists 
in these organisms and has so far escaped detection. Recent reports by LACRouTE et 
al.t~, ~5 indicate that yeast also has two activities for carbamyl phosphate synthesis. 
The regulatory behavior of enzymes seen in these experiments suggests a 
control mechanism, although the significance and the mechanism of regulation may 
be different in Neurospora than in the bacteria26, 2s. The amplitude of variation in 
specific activity in these experiments is on the order of 5- to io-fold in mutants.  
However, elevation of enzyme may be limited by starvation itself, and the conditions 
of starvation exert a profound effect (compare Tables V and VI). Without mutants 
which could be described as constitutive, therefore, it is impossible to judge the 
maximum inherent capacity of Neurospora for the synthesis of a given enzyme. The 
indications that there are two specific enzymes of carbamyl phosphate synthesis may 
be adaptively significant, in that independent end-product control of the two pathways 
may take place at this point, where ATP is used, rather than at tee point of trans- 
carbamylation. While no one enzyme may be thought of as consistently rate-limiting in 
a biosynthetic pathway 36, it appears that  the rate of citrulline synthesis is far more 
sensitive to observed changes of carbamyl phosphokinase activity than to observed 
changes in ornithine transcarbamylase activity. This is shown by varying the ratio 
of the two enzymes in experiments performed in  vitro. Furthermore, KACSER ~6 has 
shown that  a mutational reduction of argininosuccinase activity on the order of 
20-fold has no effect upon the rate of arginine synthesis or the steady-state level of 
arginine in the mycelium. It is entirely possible that the flux through the entire 
arginine pathway is most sensitive to changes of carbamyl phosphokinase activity 
in comparison to normal variations of all other enzymes. In the pyrimidine pathway, 
the synthesis of CAP~yr may be a similarly important control point, although this 
activity and aspartate transcarbamylase would be coordinately controlled if both 
were activities of a single protein. If only one protein were involved, it would be 
consistent with DONACIIIE'S aT,as results, from which he inferred that aspartate trans- 
carbamylase was the "pace-making" enzyme of pyrimidine synthesis. 
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